Scientists’ eye easy diagnosis for adenomyosis condition in women
Physicians and scientists are on the lookout for a new non-invasive diagnostic process for a lesser-known condition called adenomyosis in women.
Bharti Rana Jayshankar – Founder
She brings in more than 30 years of experience in content building, architecture, writing, editing and storytelling. Ms Jayshankar has worked in the Economic Times daily, IBT Times, Investopedia and more than a dozen content firms as a content strategist and planner.
Jay Shankar – Co-founder
He has almost three decades of experience in journalism. He has worked with national dailies such as ET, Indian Express, The Pioneer, The Hindu, Agence France Presse and Bloomberg.
Physicians and scientists are on the lookout for a new non-invasive diagnostic process for a lesser-known condition called adenomyosis in women.
The UN Secretary-General António Guterres met with 35 donor nations and appealed for the restoration of funds to a UN body working for.
More than 35 million people may have cancer in 2050 — an increase of 77% from 20 million new cases in 2022, according.
Groundwater-level declines have accelerated over the past four decades in 30% of the world’s regional aquifers, according to a study in 40 nations.
Elon Musk’s Neuralink Corp., has implanted a device in a human brain and the results show “promising neutron spike detection,” according to an.
By K. Leelamoni January 30, 2024: Globally, we find that for the last few decades, there has been a shift towards non-communicable diseases.
HQ Team January 29, 2024: Fasting diets (FDs) have gained popularity for their impact on health, disease, and weight control. Despite the vast.
Bharti Jayshankar January 29, 2024: Kayrros, an environment intelligence company, has identified the world’s 1,300 largest methane-polluting sites from space with its satellite surveillance..
HQ Team January 27, 2024: The national public health agency of the US has issued a nationwide alert to healthcare providers to track.
Bharti Jayshankar January 26, 2024: A recent UK-based BRIGhTMIND trial sheds light on the comparable effectiveness and safety of two advanced neuromodulation MRI.
We use cookies to improve your experience on our site. By using our site, you consent to cookies.
Manage your cookie preferences below:
Essential cookies enable basic functions and are necessary for the proper function of the website.
Statistics cookies collect information anonymously. This information helps us understand how visitors use our website.
Google Analytics is a powerful tool that tracks and analyzes website traffic for informed marketing decisions.
Service URL: policies.google.com